BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951 AND Diagnosis
15 results:

  • 1. A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma.
    Horvat N; Causa Andrieu P; Meier A; Ji X; Lakhman Y; Soslow R; Allison D; Gangai N; Rodriguez L; Kattan MW; Chi DS; Hricak H
    Gynecol Oncol; 2023 Sep; 176():90-97. PubMed ID: 37478617
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Who are the long-term survivors of recurrent ovarian carcinoma?: a retrospective analysis of a multicenter study.
    Yoshihara M; Mogi K; Kitami K; Uno K; Iyoshi S; Tano S; Fujimoto H; Miyamoto E; Yoshikawa N; Emoto R; Matsui S; Kajiyama H
    Int J Clin Oncol; 2022 Oct; 27(10):1660-1668. PubMed ID: 35906336
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
    Li YW; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
    [No Abstract]    [Full Text] [Related]  

  • 4. Extracellular microRNAs: key players to explore the outcomes of in vitro fertilization.
    Khan HL; Bhatti S; Abbas S; Kaloglu C; Isa AM; Younas H; Ziders R; Khan YL; Hassan Z; Turhan BO; Yildiz A; Aydin HH; Kalyan EY
    Reprod Biol Endocrinol; 2021 May; 19(1):72. PubMed ID: 33992122
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Serum lipid profiling analysis and potential marker discovery for ovarian cancer based on liquid chromatography-Mass spectrometry.
    Wang Y; Wang Y; Chen C; Ren F; Cao R; Wang Y; Han P; Zhang X; Xu C; Liu X; Xu G
    J Pharm Biomed Anal; 2021 May; 199():114048. PubMed ID: 33836461
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Markedly increased risk of malignancies in women with endometriosis.
    Eoh KJ; Han M; Kim EH; Jung I; Kim YT
    Gynecol Oncol; 2021 Apr; 161(1):291-296. PubMed ID: 33514482
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasms.
    Song XL; Ren JL; Zhao D; Wang L; Ren H; Niu J
    Eur Radiol; 2021 Jan; 31(1):368-378. PubMed ID: 32767049
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical and molecular characterization of ovarian carcinoma displaying isolated lymph node relapse.
    Hollis RL; Carmichael J; Meynert AM; Churchman M; Hallas-Potts A; Rye T; MacKean M; Nussey F; Semple CA; Herrington CS; Gourley C
    Am J Obstet Gynecol; 2019 Sep; 221(3):245.e1-245.e15. PubMed ID: 31055034
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessment of diagnostic utility of multivariate diagnostic models in differential diagnosis of ovarian tumors.
    Horała A; Swiatly A; Lorek J; Kokot ZJ; Matysiak J; Nowak-Markwitz E
    Ginekol Pol; 2018; 89(10):568-572. PubMed ID: 30393846
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases.
    Chudecka-Głaz A; Cymbaluk-Płoska A; Strojna A; Menkiszak J
    Dis Markers; 2017; 2017():9792756. PubMed ID: 28182133
    [No Abstract]    [Full Text] [Related]  

  • 11. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
    Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
    Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Evaluation of osteopontin and CA125 in detection of epithelial ovarian carcinoma.
    Milivojevic M; Boskovic V; Atanackovic J; Milicevic S; Razic S; Kotlica BK
    Eur J Gynaecol Oncol; 2013; 34(1):83-5. PubMed ID: 23590008
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
    Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
    World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diabetes mellitus and ovarian cancer (Sweden).
    Weiderpass E; Ye W; Vainio H; Kaaks R; Adami HO
    Cancer Causes Control; 2002 Oct; 13(8):759-64. PubMed ID: 12420955
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.